A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LPL / lymphoplasmacytic lymphoma

[Related PubMed/MEDLINE]
Total Number of Papers: 130
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LPL  (>> Co-occurring Abbreviation)
Long Form:   lymphoplasmacytic lymphoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. B-LPD, MZL, WM
2018 An integrated flow cytometry analysis of 286 mature B cell neoplasms identifies CD13 as a useful marker for diagnostic subtyping. CLL/SLL, FL
2018 Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience. CI, OS, WM
2018 Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation? BM, IgM, LGBLPD, WM
2018 Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of the differentiation into vulnerable subpopulation. Gln
2018 Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenstrom's macroglobulinemia. ---
2018 Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol. APCs, Ig
2018 Prognostic factors and primary treatment for Waldenstrom macroglobulinemia - a Swedish Lymphoma Registry study. OS, SLR, WM
2018 The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid. CSF, ddPCR, FFPE, NGS, PCNSL
10  2018 Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia. WM
11  2017 Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. NEAPP, PAM
12  2017 Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders. B-LPDs, HCL, HCL-v, MZL
13  2017 Follicular lymphoma with plasmacytic differentiation accompanied by monoclonal IgG gammopathy. ---
14  2017 Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia. CLL, MYD88
15  2017 Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88L265P mutation. DLBCL, WM
16  2017 Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation? DLBCL, EBV
17  2017 Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom's Macroglobulinemia. MYD88, MZL, NCCN, WM
18  2016 An uncommon case of lymphoplasmacytic lymphoma in cerebellopontine angle region: Case report with a literature review. CPA
19  2016 Bing-Neel Syndrome Case Report: A Previously Undocumented IgG Variant with MRI, PET/CT, and PET/MRI Imaging. ---
20  2016 Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma. WM
21  2016 Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas. MEMO, NHLs, WM
22  2016 Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. CLL/SLL, FL, HCL, MCL, MZL, NGS, SBCLs, SMZL
23  2016 Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. IgA, IgG, IgM, WM
24  2016 Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma. CICs
25  2016 The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. MCLs, SBLs
26  2016 [Clinical Analysis of Autologous Cytokine-induced Killer Cells Combined with IL-2 for Treating of Elderly Patients with B-cell Malignant Lymphoma]. DLBCL, HL, MALT
27  2016 [Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma]. CLL/SLL, FISH, FL, MCL, SBL, SMZL
28  2015 A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study. B-CLL, HCL, HCLv, MCL, SBCL, SDRPL, SMZL
29  2015 Intravascular large B-cell lymphoma secondary to lymphoplasmacytic lymphoma: a case report and review of literature with clonality analysis. IVLBCL
30  2015 Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). INFBCL, MZL, SLL
31  2015 Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature. MZL
32  2015 MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. BM, CLL, FFPE, MZL, WHIM
33  2015 Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia. CLL, MZL
34  2015 Treatment of patients with transformed lymphoma. FL, HT, MZL, OS, SCT, SLL/CLL
35  2015 [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]. FISH, WM
36  2014 BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma. BTK, CLL
37  2014 Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine. IgV, scFv
38  2014 Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma. BM, LPD, SMZL, WM
39  2014 Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma. CIs, HRs, WM
40  2014 Low-grade B-cell lymphoma presenting primarily in the bone marrow. Bcl-2, FL, IgH, LGBCL-NOS
41  2014 Optic nerve involvement of Waldenstrom's macroglobulinemia: with autopsy findings. CNS, MTX, WM
42  2014 Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis. WM
43  2013 An unusual case of Waldenstrom's macroglobulinemia presented with nasopharyngeal involvement. CR, WM
44  2013 IgM multiple myeloma: pathologic evaluation of a rare entity. IgM MM
45  2013 Intraclonal heterogeneity in concomitant monoclonal lymphocyte and plasma cell populations: combining flow cytometric cell sorting with molecular monoclonality profiling. ---
46  2013 Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. IgM, WM
47  2013 MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. ---
48  2013 Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. WM
49  2013 Patterns of survival in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. CI, EMRR, RSRs, WM
50  2013 Primary CNS lymphoplasmacytic lymphoma: a case report and review of literature. CNS, DLBCL, NHL, PCNSL
51  2013 Transformed lymphoplasmacytic lymphoma involving the main carina: A case report. CT
52  2013 [Case of primary lymphoplasmacytic lymphoma limited to the paratracheal mediastinum]. ---
53  2012 CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma. MGUS, PCMs
54  2012 Familial aggregation of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia with solid tumors and myeloid malignancies. WM
55  2012 Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases. gHCD
56  2012 MIST1-a novel marker of plasmacytic differentiation. MZL, PB, PCN
57  2012 MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. ---
58  2012 Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy. CAD
59  2012 Successful treatment of gamma-heavy-chain disease with rituximab and fludarabine. gamma-HCD
60  2012 [Waldenstrom macroglobulinemia complicated with chylothorax]. WM
61  2011 Development of diffuse large B-cell lymphoma in a patient with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms. CDR3, DLBCL, WM
62  2011 Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab. AITP, WM
63  2011 Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation. ---
64  2011 Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. BL, CNS, DLBCL, ECOG PS, MZBCL, PTCL
65  2011 Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma. FCM, MGUS, MM, MRD
66  2011 Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report. WM
67  2011 What causes Waldenstrom's macroglobulinemia: genetic or immune-related factors, or a combination? WM
68  2011 [Cytogenetic and clinical study on 126 cases of B cell non-Hodgkin's lymphoma with bone marrow involvement]. B-NHL, CA, CC, DLBCL, FL, MCL, MZL, OS, SLL
69  2010 Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. BM, DLBCL, FC, NHL
70  2010 Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea. CHOP
71  2010 Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma. B-ALL, B-CLL, B-NHL NOS, DLBCL, FCL, MCL, MM, MZL, T-NHL
72  2010 Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. CIs, ORs
73  2010 Two case reports of non-secretory [correction of non-secretary]-Ig types of lymphoplasmacytic lymphoma (LPL). ---
74  2010 [Clinicopathologic features of lymphoplasmacytic lymphoma]. ---
75  2009 Amyloidosis, Evans syndrome and management options of lymphoplasmacytic lymphoma. AMI, ES, GI
76  2009 Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations. ---
77  2009 IgG-lambda secreting B-lymphoplasmacytic lymphoma with disseminated cutaneous infiltration: report of a rare case. ---
78  2009 Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement. ---
79  2009 The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). GLSG, OR, R-CHOP, TTF, WM
80  2009 [Lymphoplasmacytic lymphoma with a breast tumor and IgG+IgA type biclonal gammopathy]. ---
81  2009 [Lymphoplasmacytic lymphoma with Waldenstrom's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients]. WM
82  2008 CD45 expression in low-grade B-cell non-Hodgkin's lymphomas. CLL, FL, HCL, MCL, MFI, MZL, NHL
83  2008 Cytological detection of lymphoma in Douglas aspirate. NHL, PEL, SRCT
84  2008 Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. FICTION, VN-P
85  2008 Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia. WM
86  2007 Promoter hypermethylation of multiple genes in gastric lymphoma. BL, DLBCL, FL, MZL, PGL
87  2007 t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma. ---
88  2006 Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients outcome. CLL, CR, FL, HCL, HP, HR, MCL, MZL, RTX
89  2006 FISH detection of t(14;18) in follicular lymphoma on Papanicolaou-stained archival cytology slides. FISH, FL, IgH, MCL, MZL, RLT, SLL/CLL
90  2005 Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Ig, MALT, MZLs, NMZL, SMZL, WM
91  2005 Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma. FISH, WM
92  2005 Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. MALT
93  2005 Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. IgH, PAX5
94  2005 Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. VH, WM
95  2005 Mantle cell lymphoma presenting with paraproteinemia. FCM, IH, MCL, MZL, WM
96  2005 Patient with immunoproliferative disease and lung carcinoma: a case report. NHL
97  2005 PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. FISH, HRTR-BCLs, M-FISH
98  2005 Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders. i.v, SLVL, WM
99  2004 Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment. MGUS, MM
100  2004 Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma. CLL, HCL, WM